Interactions Between MFAP5 + fibroblasts and Tumor-infiltrating Myeloid Cells Shape the Malignant Microenvironment of Colorectal Cancer
Overview
General Medicine
Affiliations
Background: The therapeutic targeting of the tumor microenvironment (TME) in colorectal cancer (CRC) has not yet been fully developed and utilized because of the complexity of the cell-cell interactions within the TME. The further exploration of these interactions among tumor-specific clusters would provide more detailed information about these communication networks with potential curative value.
Methods: Single-cell RNA sequencing, spatial transcriptomics, and bulk RNA sequencing datasets were integrated in this study to explore the biological properties of MFAP5 + fibroblasts and their interactions with tumor-infiltrating myeloid cells in colorectal cancer. Immunohistochemistry and multiplex immunohistochemistry were performed to confirm the results of these analyses.
Results: We profiled heterogeneous single-cell landscapes across 27,414 cells obtained from tumors and adjacent tissues. We mainly focused on the pro-tumorigenic functions of the identified MFAP5 + fibroblasts. We demonstrated that tumor-resident MFAP5 + fibroblasts and myeloid cells (particularly C1QC + macrophages) were positively correlated in both spatial transcriptomics and bulk RNA-seq public cohorts. These cells and their interactions might shape the malignant behavior of CRC. Intercellular interaction analysis suggested that MFAP5 + fibroblasts could reciprocally communicate with C1QC + macrophages and other myeloid cells to remodel unfavorable conditions via MIF/CD74, IL34/CSF1R, and other tumor-promoting signaling pathways.
Conclusion: Our study has elucidated the underlying pro-tumor mechanisms of tumor-resident MFAP5 + fibroblasts and provided valuable targets for the disruption of their properties.
Wang Y, Qiu X, Li Q, Qin J, Ye L, Zhang X J Transl Med. 2025; 23(1):175.
PMID: 39934919 PMC: 11817247. DOI: 10.1186/s12967-025-06103-3.
Chen W, Hu K, Liu Y, Li X, Chen L, Duan S Transl Cancer Res. 2024; 13(9):4555-4573.
PMID: 39430854 PMC: 11483459. DOI: 10.21037/tcr-24-546.
Mao C, Chen Y, Xing D, Zhang T, Lin Y, Long C Elife. 2024; 13.
PMID: 39387546 PMC: 11466454. DOI: 10.7554/eLife.97201.
Scoping Review: Methods and Applications of Spatial Transcriptomics in Tumor Research.
Maciejewski K, Czerwinska P Cancers (Basel). 2024; 16(17).
PMID: 39272958 PMC: 11394603. DOI: 10.3390/cancers16173100.
Deep learning-based multimodal spatial transcriptomics analysis for cancer.
Rajdeo P, Aronow B, Surya Prasath V Adv Cancer Res. 2024; 163:1-38.
PMID: 39271260 PMC: 11431148. DOI: 10.1016/bs.acr.2024.08.001.